Joe Hazelton joined the Company in November 2021, as our Chief Business Officer, and was appointed to the position of Chief Operating Officer on March 26, 2024, and then the President on June 2, 2025. Mr. Hazelton brings over 20 years of pharmaceutical industry experience to Dyadic in key growth areas of product and business development, licensing, and commercialization. He joined Dyadic from Charleston Laboratories, Inc. ("Charleston”), where he has served as Chief Operating Officer and Chief Commercial Officer, responsible for the strategic management of Charleston’s product and portfolio management, alliance management, regulatory oversight, and global commercialization activities. Prior to Charleston, Mr. Hazelton began his career at Novartis Pharmaceuticals Corporation ("Novartis”), where over 15 years, he ascended to roles of increasing responsibility based on his leadership, innovation, and results. While at Novartis, Mr. Hazelton held leadership positions within the core functions of sales, marketing, market access, pricing, contracting, and strategic alliances for various retail and specialty pharmaceuticals across a broad spectrum of therapeutic areas and several blockbuster products. Neither Charleston nor Novartis is a parent, subsidiary or other affiliate of Dyadic. Mr. Hazelton earned his B.A. from the College of the Holy Cross in Worcester, MA.
What is Joseph P. Hazelton's net worth?
The estimated net worth of Joseph P. Hazelton is at least $71.46 thousand as of August 1st, 2025. Mr. Hazelton owns 155,340 shares of Dyadic International stock worth more than $71,456 as of October 2nd. This net worth estimate does not reflect any other assets that Mr. Hazelton may own. Learn More about Joseph P. Hazelton's net worth.
How do I contact Joseph P. Hazelton?
Has Joseph P. Hazelton been buying or selling shares of Dyadic International?
Joseph P. Hazelton has not been actively trading shares of Dyadic International during the last quarter. Most recently, on Friday, August 1st, Joseph P. Hazelton bought 26,000 shares of Dyadic International stock. The stock was acquired at an average cost of $0.95 per share, with a total value of $24,700.00. Following the completion of the transaction, the chief operating officer now directly owns 155,340 shares of the company's stock, valued at $147,573. Learn More on Joseph P. Hazelton's trading history.
Who are Dyadic International's active insiders?
Are insiders buying or selling shares of Dyadic International?
In the last twelve months, insiders at the biotechnology company sold shares 1 times. They sold a total of 2,616 shares worth more than $3,165.36. The most recent insider tranaction occured on July, 24th when Major Shareholder Francisco Trust Under Agreemen sold 2,616 shares worth more than $3,165.36. Insiders at Dyadic International own 20.9% of the company.
Learn More about insider trades at Dyadic International. Information on this page was last updated on 7/24/2026.
